首页 | 本学科首页   官方微博 | 高级检索  
     

珠子肝泰治疗慢性乙型肝炎的免疫组织化学研究
引用本文:陈义,蔡艳梅,吴斌,马涛. 珠子肝泰治疗慢性乙型肝炎的免疫组织化学研究[J]. 中西医结合肝病杂志, 2003, 13(1): 6-7
作者姓名:陈义  蔡艳梅  吴斌  马涛
作者单位:1. 兰州肝病研究所临床研究室,甘肃,兰州,730046
2. 兰州市第二人民医院
摘    要:目的:观察珠子肝泰对慢性乙型肝炎患者肝组织内HBsAg和HBcAg的影响。方法:对21例慢性乙型肝炎应用珠子肝泰进行治疗,3次/d,每次4粒(0.8g),疗程6个月。 在治疗开始前和疗程结束后采集血清和肝细胞标本,进行血清学、病理学和免疫组织化学检查。结果:治疗后、血清内HBeAg和HBV DNA的转阴率分别为45.0%和47.4%,81%的患者肝组织损伤改善或修复,45.4%的患者肝纤维化程度减轻,肝内HBsAg和HBcAg的转阴率分别为19.0%和23.8%。结论:珠子肝泰在抑制慢性乙型肝炎患者血清HBV复制标志和改善肝组织病理损伤程度的同时,对肝细胞内乙肝病毒感染因子也有一定抑制作用。

关 键 词:乙型肝炎 中医学 珠子肝泰/治疗应用 免疫组织化学
修稿时间:2002-08-13

Study on Immune Histochemistry of Chronic Hepatitis B Patients Treated with Zhuzi Gantai (ZGT)
CHEN Yi,CAI Yanmei,WU Bin,et al.. Study on Immune Histochemistry of Chronic Hepatitis B Patients Treated with Zhuzi Gantai (ZGT)[J]. Chinese Journal of Integrated Traditonal and Western Medicine on Liver Diseases, 2003, 13(1): 6-7
Authors:CHEN Yi  CAI Yanmei  WU Bin  et al.
Affiliation:CHEN Yi,CAI Yanmei,WU Bin,et al. Lanzhou Institute of Liver Diseases
Abstract:Objective: To observe the effects of ZGT on HBsAg and HBcAg in patients with chronic hepatitis B. Methods: 21 patients with chronic hepatitis B were treated with ZGT three times daily for 6 months. The serum levels, pathology and immune histochemistry of all patients were detected before and after treatment. Results: At the end of the treatment, the seronegation of HBeAg and HBV DNA were 45.0 % and 47.4 % , negative rate of HBsAg and HBcAg in liver were 19.0% and 23.8% , the liver function of 81% patients were improved, and the degrees of the liver fibrosis of the 45% patients were lessened. Conclusion: The results suggested that ZGT could inhibit the replications of HBV, improve the liver function and affect the infected factor of Hepatitis B virus.
Keywords:TCM Science  Zhuzi Gantai/Therapeutic Use  Immunohistochemistry  Hepatitis   Viral   Human  Chronic Hepatitis B  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号